203 related articles for article (PubMed ID: 11248654)
21. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
[TBL] [Abstract][Full Text] [Related]
22. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat.
Hodsman AB; Watson PH; Drost D; Holdsworth D; Thornton M; Hock J; Bryant H; Fraher LJ
Bone; 1999 May; 24(5):451-5. PubMed ID: 10321904
[TBL] [Abstract][Full Text] [Related]
23. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
[TBL] [Abstract][Full Text] [Related]
24. Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet.
Yano T; Yamada M; Konda T; Shiozaki M; Inoue D
J Bone Miner Metab; 2014 Nov; 32(6):653-9. PubMed ID: 24357144
[TBL] [Abstract][Full Text] [Related]
25. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
26. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats.
Thomsen JS; Mosekilde LI; Gasser JA
Bone; 1999 Nov; 25(5):561-9. PubMed ID: 10574576
[TBL] [Abstract][Full Text] [Related]
27. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration.
Kishi T; Hagino H; Kishimoto H; Nagashima H
Bone; 1998 May; 22(5):515-22. PubMed ID: 9600786
[TBL] [Abstract][Full Text] [Related]
28. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
29. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia.
Shen V; Dempster DW; Mellish RW; Birchman R; Horbert W; Lindsay R
Calcif Tissue Int; 1992 Mar; 50(3):214-20. PubMed ID: 1617495
[TBL] [Abstract][Full Text] [Related]
30. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
32. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
Li QN; Jee WS; Ma YF; Ke HZ; Xie H; Huang LF; Liang NC
Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
[TBL] [Abstract][Full Text] [Related]
33. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
[TBL] [Abstract][Full Text] [Related]
34. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W
J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
[TBL] [Abstract][Full Text] [Related]
37. The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats.
Bagi C; van der Meulen M; Brommage R; Rosen D; Sommer A
Bone; 1995 May; 16(5):559-65. PubMed ID: 7544602
[TBL] [Abstract][Full Text] [Related]
38. The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu27]cyclo(Glu22-Lys26)hPTH-(1-31)NH2, and hPTH-(1-30)NH2.
Whitfield JF; Morley P; Fraher L; Hodsman AB; Holdsworth DW; Watson PH; Willick GE; Barbier JR; Gulam M; Isaacs RJ; MacLean S; Ross V
Calcif Tissue Int; 2000 Apr; 66(4):307-12. PubMed ID: 10742450
[TBL] [Abstract][Full Text] [Related]
39. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
[TBL] [Abstract][Full Text] [Related]
40. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.
Søgaard CH; Wronski TJ; McOsker JE; Mosekilde L
Endocrinology; 1994 Feb; 134(2):650-7. PubMed ID: 8299562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
